118 related articles for article (PubMed ID: 3698510)
1. Eel calcitonin suppresses plasma human calcitonin levels in medullary carcinoma of the thyroid.
Morimoto S; Miyauchi A; Fukuo K; Imanaka S; Yamamoto H; Tsuchiya H; Koh E; Yukawa S; Onishi T; Avioli LV
Clin Sci (Lond); 1986 Apr; 70(4):333-8. PubMed ID: 3698510
[TBL] [Abstract][Full Text] [Related]
2. Stability of [Asu1,7]-eel calcitonin and eel calcitonin in vitro and in vivo.
Yamauchi H; Shiraki M; Otani M; Matsuo M; Orimo H
Endocrinol Jpn; 1977 Jun; 24(3):281-5. PubMed ID: 913338
[TBL] [Abstract][Full Text] [Related]
3. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
4. Effects of [Asu1,7]-eel calcitonin on gastric somatostatin and gastrin release.
Chiba T; Taminato T; Kadowaki S; Goto Y; Mori K; Seino Y; Abe H; Chihara K; Matsukura S; Fujita T; Kondo T
Gut; 1980 Feb; 21(2):94-7. PubMed ID: 6103860
[TBL] [Abstract][Full Text] [Related]
5. Bimodal action of [Asu1,7]eel-calcitonin on phosphoinositide hydrolysis in cultured anterior pituitary cells.
Sortino MA; Canonico PL; Clementi G
Eur J Pharmacol; 1991 Aug; 207(4):345-50. PubMed ID: 1664337
[TBL] [Abstract][Full Text] [Related]
6. Meal-related changes in plasma calcitonin levels in patients with medullary thyroid carcinoma.
Miyauchi A; Morimoto S; Onishi T; Takai S; Okada Y; Himeno S; Kosaki G; Kumahara Y
Endocrinol Jpn; 1980 Apr; 27(2):153-6. PubMed ID: 7190894
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of eel-calcitonin and (asu1,7)-eel-calcitonin: contribution of the disulfide bond to the hormonal activity.
Morikawa T; Munekata E; Sakakibara S; Noda T; Otani M
Experientia; 1976 Sep; 32(9):1104-6. PubMed ID: 971732
[TBL] [Abstract][Full Text] [Related]
10. Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid.
Sizemore GW; Go VL; Kaplan EL; Sanzenbacher LJ; Holtermuller KH; Arnaud CD
N Engl J Med; 1973 Mar; 288(13):641-4. PubMed ID: 4734496
[No Abstract] [Full Text] [Related]
11. Comparative effects of eel calcitonin, salmon calcitonin and [Asu1,7]eel calcitonin on hypophyseal and osteoblastic function.
Sortino MA; Aleppo G; Scapagnini U; Canonico PL
Gynecol Endocrinol; 1993 Jun; 7(2):89-96. PubMed ID: 8213232
[TBL] [Abstract][Full Text] [Related]
12. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
Gharib H; Kao PC; Heath H
Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system effect of calcitonin: stimulation of prolactin release in rats.
Chihara K; Iwasaki J; Iwasaki Y; Minamitani N; Kaji H; Fujita T
Brain Res; 1982 Sep; 248(2):331-9. PubMed ID: 6215972
[TBL] [Abstract][Full Text] [Related]
14. Effects of bovine parathyroid extract and [Asu1,7]-eel calcitonin on 35S incorporation into chick embryonic cartilage.
Kawai K; Yamashita K; Ogata E
Endocrinol Jpn; 1982 Aug; 29(4):479-82. PubMed ID: 7151746
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum calcitonin levels in patients with thyroid disorders.
Oishi S; Shimada T; Tajiri J; Inoue J; Sato T
Acta Endocrinol (Copenh); 1984 Dec; 107(4):476-81. PubMed ID: 6516695
[TBL] [Abstract][Full Text] [Related]
16. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma.
O'Dorisio TM; Falko JM; Cataland S; Almoney RW; George JM; Mazzaferri EL; Reynolds JC
J Clin Endocrinol Metab; 1982 Apr; 54(4):798-802. PubMed ID: 7061688
[TBL] [Abstract][Full Text] [Related]
17. A new approach for calcitonin determination based on target cell responsiveness.
Zaidi M; Chambers TJ; Moonga BS; Oldoni T; Passarella E; Soncini R; MacIntyre I
J Endocrinol Invest; 1990 Feb; 13(2):119-26. PubMed ID: 2329259
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of centrally administered /ASU1-7/eel calcitonin on basal and stimulated prolactin release in rats.
Sibilia V; Netti C; Guidobono F; Villa I; Pecile A
J Endocrinol Invest; 1990 Jun; 13(6):507-11. PubMed ID: 2258579
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
[TBL] [Abstract][Full Text] [Related]
20. Gastro-intestinal polypeptides in patients treated for medullary carcinoma of the thyroid.
Rasmusson B
Acta Endocrinol (Copenh); 1984 May; 106(1):112-5. PubMed ID: 6375228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
